InvestorsHub on MSN

Barinthus Bio reports 2025 results and moves forward with planned Clywedog merger

On March 13, 2026, Barinthus Bio (NASDAQ:BRNS) released its full-year 2025 financial results, highlighting plans for an ...
Yahoo Finance

Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B

OXFORD, United Kingdom, June 06, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), a biopharmaceutical company developing novel T cell immunotherapeutic candidates, today ...
Nasdaq

Vaccitech’s VTP-300 was Well-Tolerated and Induced T cells against all targeted HBV antigens in both Healthy Volunteers and Patients with Chronic HBV Infection in Interim ...

Interim data from two studies, HBV001 and HBV002, showed that in chronic Hepatitis B (CHB) patients the heterologous prime-boost vector combination, ChAdOx1-HBV + MVA-HBV (VTP-300), induced robust T ...
Network World

VTP Clients Updating Servers (and Answers to Questions)

When I first heard that a VTP client can update a VTP server under the right conditions, I was frankly a non-believer. No way. I’d seen evidence to the contrary in several documents at cisco.com and ...
Yahoo Finance

Vaccitech’s VTP-300 induced sustained reductions of surface antigen in patients with chronic hepatitis B both as a monotherapy and in combination with a single low dose of ...

OXFORD, United Kingdom, June 22, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics ...
Investing

Vanguard Total Inflation-Protected Securities ETF (VTP)

Vanguard Malvern Funds - Vanguard Total Inflation-Protected Securities ETF is an exchange traded fund launched and managed by The Vanguard Group, Inc. It invests in fixed income markets of the United ...